Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that has spread to more than 70 countries worldwide since 2015. Despite active research, there are currently no licensed vaccines or therapeutics. We have previously reported the development of various adenoviral vectored vaccine candidates...
Asıl Yazarlar: | López-Camacho, C, Kim, Y, Abbink, P, Larocca, R, Huiskonen, J, Barouch, D, Reyes-Sandoval, A |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
MDPI
2019
|
Benzer Materyaller
-
Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
Yazar:: César López-Camacho, ve diğerleri
Baskı/Yayın Bilgisi: (2019-11-01) -
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
Yazar:: Moorthy, V, ve diğerleri
Baskı/Yayın Bilgisi: (2003) -
New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
Yazar:: Alharbi, N
Baskı/Yayın Bilgisi: (2014) -
Clinical development of Modified Vaccinia virus Ankara vaccines.
Yazar:: Gilbert, S
Baskı/Yayın Bilgisi: (2013) -
Clinical development of Modified Vaccinia virus Ankara vaccines
Yazar:: Gilbert, S
Baskı/Yayın Bilgisi: (2013)